Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)

by Moehler Markus, Dufour Patrick, Bachellier Phillippe, Raoul Jean-Luc, Delpero Jean-Robert, Laurent Stéphanie, Berrevoet Frederik, Lesurtel Mickael, Pestalozzi Bernhard, Heinrich Stefan, Weber Achim, Lang Hauke, Rogiers Xavier, Clavien Pierre-Alain
Published 2011-08-01